These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 24618664

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Successful pregnancy in maple syrup urine disease: a case report and review of the literature.
    Grünert SC, Rosenbaum-Fabian S, Schumann A, Schwab KO, Mingirulli N, Spiekerkoetter U.
    Nutr J; 2018 May 12; 17(1):51. PubMed ID: 29753318
    [Abstract] [Full Text] [Related]

  • 3. Diagnosis and treatment of maple syrup disease: a study of 36 patients.
    Morton DH, Strauss KA, Robinson DL, Puffenberger EG, Kelley RI.
    Pediatrics; 2002 Jun 12; 109(6):999-1008. PubMed ID: 12042535
    [Abstract] [Full Text] [Related]

  • 4. Total parenteral nutrition therapy of toxic maple syrup urine disease.
    Townsend I, Kerr DS.
    Am J Clin Nutr; 1982 Aug 12; 36(2):359-65. PubMed ID: 6808824
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Total branched-chain amino acids requirement in patients with maple syrup urine disease by use of indicator amino acid oxidation with L-[1-13C]phenylalanine.
    Riazi R, Rafii M, Clarke JT, Wykes LJ, Ball RO, Pencharz PB.
    Am J Physiol Endocrinol Metab; 2004 Jul 12; 287(1):E142-9. PubMed ID: 14970005
    [Abstract] [Full Text] [Related]

  • 10. Management of acute decompensation of neonatal maple syrup urine disease with continuous arteriovenous haemofiltration: report of one case.
    Lin MC, Chen CH, Fu LS, Jan SL, Shu SG, Chi CS.
    Acta Paediatr Taiwan; 2002 Jul 12; 43(5):281-4. PubMed ID: 12607485
    [Abstract] [Full Text] [Related]

  • 11. [Maple Syrup Urine Disease in a newborn infant].
    Mazur A, Sykut-Cegielska J, Ciebiera M, Trzeciak J, Taybert J, Kowalik A, Ołtarzewski M.
    Med Wieku Rozwoj; 2007 Jul 12; 11(1):65-8. PubMed ID: 17965467
    [Abstract] [Full Text] [Related]

  • 12. Tailoring of the diet for the individual in maple syrup urine disease: long-term home dietary treatment of an adult patient with MSUD by monitoring of daily intake with a personal computer. A case report.
    Lie IE, Haugstad S, Holm H.
    Hum Nutr Appl Nutr; 1985 Apr 12; 39(2):130-6. PubMed ID: 3839494
    [Abstract] [Full Text] [Related]

  • 13. Second-tier test for quantification of alloisoleucine and branched-chain amino acids in dried blood spots to improve newborn screening for maple syrup urine disease (MSUD).
    Oglesbee D, Sanders KA, Lacey JM, Magera MJ, Casetta B, Strauss KA, Tortorelli S, Rinaldo P, Matern D.
    Clin Chem; 2008 Mar 12; 54(3):542-9. PubMed ID: 18178665
    [Abstract] [Full Text] [Related]

  • 14. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease.
    McMahon Y, MacDonnell RC.
    Adv Perit Dial; 1990 Mar 12; 6():31-4. PubMed ID: 1982835
    [Abstract] [Full Text] [Related]

  • 15. [Compliance of the diet restricted with leucine, isoleucine and valine in maple syrup urine disease (MSUD) children].
    Kowalik A, Narojek L, Sykut-Cegielska J.
    Rocz Panstw Zakl Hig; 2007 Mar 12; 58(1):95-101. PubMed ID: 17711097
    [Abstract] [Full Text] [Related]

  • 16. Acrodermatitis enteropathica-like eruption during treatment of maple syrup urine disease: report of one case.
    Tain YL, Huang SC, Hung FC, Wang HS, Sun PC.
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996 Mar 12; 37(5):357-60. PubMed ID: 8942030
    [Abstract] [Full Text] [Related]

  • 17. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease.
    Jouvet P, Jugie M, Rabier D, Desgrès J, Hubert P, Saudubray JM, Man NK.
    Intensive Care Med; 2001 Nov 12; 27(11):1798-806. PubMed ID: 11810125
    [Abstract] [Full Text] [Related]

  • 18. Branched-chain α-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes.
    Strauss KA, Carson VJ, Soltys K, Young ME, Bowser LE, Puffenberger EG, Brigatti KW, Williams KB, Robinson DL, Hendrickson C, Beiler K, Taylor CM, Haas-Givler B, Chopko S, Hailey J, Muelly ER, Shellmer DA, Radcliff Z, Rodrigues A, Loeven K, Heaps AD, Mazariegos GV, Morton DH.
    Mol Genet Metab; 2020 Mar 12; 129(3):193-206. PubMed ID: 31980395
    [Abstract] [Full Text] [Related]

  • 19. Oxidative stress in plasma from maple syrup urine disease patients during treatment.
    Barschak AG, Sitta A, Deon M, Barden AT, Dutra-Filho CS, Wajner M, Vargas CR.
    Metab Brain Dis; 2008 Mar 12; 23(1):71-80. PubMed ID: 18026828
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification.
    Heldt K, Schwahn B, Marquardt I, Grotzke M, Wendel U.
    Mol Genet Metab; 2005 Apr 12; 84(4):313-6. PubMed ID: 15781191
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.